Stock analysts at StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the medical instruments supplier’s stock.
Pro-Dex Trading Up 1.2 %
NASDAQ:PDEX opened at $16.60 on Monday. Pro-Dex has a one year low of $12.40 and a one year high of $26.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.39 and a current ratio of 2.73. The firm has a market cap of $59.43 million, a P/E ratio of 15.96 and a beta of 0.94. The firm has a 50-day simple moving average of $18.20 and a 200-day simple moving average of $16.99.
Pro-Dex (NASDAQ:PDEX – Get Rating) last posted its quarterly earnings results on Thursday, August 25th. The medical instruments supplier reported $0.38 EPS for the quarter. Pro-Dex had a net margin of 8.97% and a return on equity of 16.75%. The business had revenue of $12.62 million during the quarter.
Institutional Inflows and Outflows
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.